Proposed Collection; 60-Day Comment Request; Awareness and Beliefs About Cancer Survey, National Cancer Institute (NCI), 36788-36789 [2013-14643]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
36788
Federal Register / Vol. 78, No. 118 / Wednesday, June 19, 2013 / Notices
nonclinical paradigm for assessing
Torsade de Pointes (TdP) risk and
explore the parameters for an
appropriate, strong, nonclinical
proarrthymia screening method as an
alternative to clinical Thorough QT
studies. The workshop, which will seek
input from all attendees, is intended to
provide a forum for stakeholders,
including experts and opinion leaders
from academia, industry, and regulatory
agencies in the United States, the
European Union, Canada, and Asian
countries, to discuss what a new
framework might look like, the benefits
and limitations of the current
guidelines, and the importance of a
uniform assay schema.
Date and Time: The public workshop
will be held on July 23, 2013, from 8
a.m. to 6 p.m.
Location: The public workshop will
be held at the FDA White Oak Campus,
10903 New Hampshire Ave., Building
31 Conference Center, the Great Room
(rm. 1503), Silver Spring, MD 20993.
Contact Person: Devi Kozeli, Center
for Drug Evaluation and Research, Food
and Drug Administration, 10903 New
Hampshire Ave., Bldg. 22, rm. 4183,
Silver Spring, MD 20993, 301–796–
1128, email: devi.kozeli@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
This workshop will introduce for
discussion a new nonclinical paradigm
for assessing TdP risk and explore the
parameters for an appropriate, strong,
nonclinical proarrthymia screening
method as an alternative to clinical
Thorough QT studies. The workshop,
which will seek input from all
attendees, is intended to provide a
forum for stakeholders, including
experts and opinion leaders from
academia, industry, and regulatory
agencies in the United States, the
European Union, Canada, and Asian
countries, to discuss what a new
framework might look like, the benefits
and limitations of the current
guidelines, and the importance of a
uniform assay schema.
A description of the planned activities
for the workshop can be found at: https://
www.hesiglobal.org/i4a/pages/
index.cfm?pageID=3620 (FDA has
verified this online address but is not
responsible for subsequent changes to
the Web site where it is located after
this document publishes in the Federal
Register.)
Registration and Accommodations:
Registration for non-FDA attendees
should be performed online at the
following address: https://evm.auxserv.
duke.edu/iebms/reg/reg_p1_form.aspx?
VerDate Mar<15>2010
17:13 Jun 18, 2013
Jkt 229001
oc=10&ct=DCRIHBD09&eventid=50715.
(FDA has verified this online address
but is not responsible for subsequent
changes to the Web site where it is
located after this document publishes in
the Federal Register.)
Registration for FDA attendees is also
online, at the following address: https://
duke.qualtrics.com/SE/?SID=SV_bmv
7T8GPm4IAPd3.
The registration deadline for paying
attendees is July 15, 2013. With the
exception of FDA employees and a
limited number of speakers or
organizers, registrants must pay a
registration fee covering the cost of
facilities, materials, and food. The
registration fees for different categories
of attendee are as follows:
Written comments and/or suggestions
from the public and affected agencies
are invited on one or more of the
following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
Category
Cost
technological collection techniques or
other forms of information technology.
Commercial Entity or Industry, Not
To Submit Comments and for Further
Members of HESI ...........................
$950
Information: To obtain a copy of the
Commercial Entity or Industry, HESI
Members .........................................
600 data collection plans and instruments,
Academia, Professional Society, or
submit comments in writing, or request
Nonprofit Organization ....................
250 more information on the proposed
Government (non-FDA) ......................
150 project, contact: Sarah Kobrin, Division
of Cancer Control and Population
Seats are limited, and conference
Sciences, 9609 Medical Center Dr., MSC
space will be filled in the order in
9761, Rockville, MD 20852, or call nonwhich registrations are received.
toll-free number 240–276–6931 or Email
Attendees are responsible for their own
your request, including your address to:
accommodations.
kobrins@mail.nih.gov. Formal requests
If you need special accommodations
for additional plans and instruments
due to a disability, please contact Devi
must be requested in writing.
Kozeli (see Contact Person) at least 7
Comment Due Date: Comments
days in advance.
regarding this information collection are
Dated: June 12, 2013.
best assured of having their full effect if
Leslie Kux,
received within 60 days of the date of
this publication.
Assistant Commissioner for Policy.
Proposed Collection: Awareness and
[FR Doc. 2013–14580 Filed 6–18–13; 8:45 am]
Beliefs about Cancer Survey, 0925–
BILLING CODE 4160–01–P
NEW, National Cancer Institute (NCI),
National Institutes of Health (NIH).
DEPARTMENT OF HEALTH AND
Need and Use of Information
HUMAN SERVICES
Collection: The objective of the study is
gather data about American adults’
National Institutes of Health
awareness and beliefs about cancer. The
ultimate goal is to determine how
Proposed Collection; 60-Day Comment
individuals’ perceptions of cancer may
Request; Awareness and Beliefs About
influence their decisions to report signs
Cancer Survey, National Cancer
and symptoms to health care providers,
Institute (NCI)
perhaps affecting the disease stage of
diagnosis and the effectiveness of
Summary: In compliance with the
treatment. Data will be collected from
requirement of Section 3506(c)(2)(A) of
approximately 2,000 adults aged 50
the Paperwork Reduction Act of 1995,
years or older across the United States
for opportunity for public comment on
for the NCI Awareness and Beliefs about
proposed data collection projects, the
Cancer survey over a one-year period.
National Cancer Institute (NCI),
National Institutes of Health (NIH) will
OMB approval is requested for one
publish periodic summaries of proposed year. There are no costs to respondents
projects to be submitted to the Office of
other than their time. The total
Management and Budget (OMB) for
estimated annualized burden hours are
review and approval.
1,334.
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
E:\FR\FM\19JNN1.SGM
19JNN1
36789
Federal Register / Vol. 78, No. 118 / Wednesday, June 19, 2013 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Type of
respondent
Screener ............................................
Survey ...............................................
Adults 50+ years old ........................
General Public ..................................
Dated: June 11, 2013.
Vivian Horovitch-Kelley,
NCI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. 2013–14643 Filed 6–18–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Arthritis,
Bone and Skeletal Biology.
Date: July 12, 2013.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Aruna K Behera, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4211,
MSC 7814, Bethesda, MD 20892, 301–435–
6809, beheraak@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Biochemistry & Macromolecular
Biophysics.
Date: July 15–17, 2013.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: James W Mack, Ph.D.,
Scientific Review Officer, Center for
VerDate Mar<15>2010
17:13 Jun 18, 2013
Jkt 229001
Number of
respondents
8,000
2,000
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4154,
MSC 7806, Bethesda, MD 20892, (301) 435–
2037, mackj2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Fellowship:
Physiology and Pathobiology of
Musculoskeletal, Oral, and Skin Systems.
Date: July 15, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Anshumali Chaudhari,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4124,
MSC 7802, Bethesda, MD 20892, (301) 435–
1210, chaudhaa@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Chemistry, Biochemistry and
Biophysics.
Date: July 17–18, 2013.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Michael Eissenstat, Ph.D.,
Scientific Review Officer, BCMB IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4166,
MSC 7806, Bethesda, MD 20892, 301–435–
1722, eissenstatma@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–13–
008: Shared Instrumentation: X-ray.
Date: July 17, 2013.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: William A. Greenberg,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4168,
MSC 7806, Bethesda, MD 20892, (301) 435–
1726, greenbergwa@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846-93.878, 93.892, 93.893, National
Institutes of Health, HHS)
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
1
1
Total annual
burden hour
5/60
20/60
667
667
Dated: June 13, 2013.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–14497 Filed 6–18–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis And
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; NIAMS
Small Grant Program for New Investigators
(R03).
Date: July 11–12, 2013.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, Suite 800, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Kan Ma, Ph.D., Scientific
Review Officer, Scientific Review Branch,
National Institute of Arthritis,
Musculoskeletal and Skin Diseases, NIH,
6701 Democracy Boulevard, Suite 800,
Bethesda, MD 20892, 301–451–4838,
mak2@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
E:\FR\FM\19JNN1.SGM
19JNN1
]]>Agencies
[Federal Register Volume 78, Number 118 (Wednesday, June 19, 2013)]
[Notices]
[Pages 36788-36789]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-14643]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment Request; Awareness and
Beliefs About Cancer Survey, National Cancer Institute (NCI)
Summary: In compliance with the requirement of Section
3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity
for public comment on proposed data collection projects, the National
Cancer Institute (NCI), National Institutes of Health (NIH) will
publish periodic summaries of proposed projects to be submitted to the
Office of Management and Budget (OMB) for review and approval.
Written comments and/or suggestions from the public and affected
agencies are invited on one or more of the following points: (1)
Whether the proposed collection of information is necessary for the
proper performance of the function of the agency, including whether the
information will have practical utility; (2) The accuracy of the
agency's estimate of the burden of the proposed collection of
information, including the validity of the methodology and assumptions
used; (3) Ways to enhance the quality, utility, and clarity of the
information to be collected; and (4) Ways to minimize the burden of the
collection of information on those who are to respond, including the
use of appropriate automated, electronic, mechanical, or other
technological collection techniques or other forms of information
technology.
To Submit Comments and for Further Information: To obtain a copy of
the data collection plans and instruments, submit comments in writing,
or request more information on the proposed project, contact: Sarah
Kobrin, Division of Cancer Control and Population Sciences, 9609
Medical Center Dr., MSC 9761, Rockville, MD 20852, or call non-toll-
free number 240-276-6931 or Email your request, including your address
to: kobrins@mail.nih.gov. Formal requests for additional plans and
instruments must be requested in writing.
Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60 days
of the date of this publication.
Proposed Collection: Awareness and Beliefs about Cancer Survey,
0925-NEW, National Cancer Institute (NCI), National Institutes of
Health (NIH).
Need and Use of Information Collection: The objective of the study
is gather data about American adults' awareness and beliefs about
cancer. The ultimate goal is to determine how individuals' perceptions
of cancer may influence their decisions to report signs and symptoms to
health care providers, perhaps affecting the disease stage of diagnosis
and the effectiveness of treatment. Data will be collected from
approximately 2,000 adults aged 50 years or older across the United
States for the NCI Awareness and Beliefs about Cancer survey over a
one-year period.
OMB approval is requested for one year. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 1,334.
[[Page 36789]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Type of Number of Number of burden per Total annual
Form name respondent respondents responses per response (in burden hour
respondent hours)
----------------------------------------------------------------------------------------------------------------
Screener...................... Adults 50+ years 8,000 1 5/60 667
old.
Survey........................ General Public.. 2,000 1 20/60 667
----------------------------------------------------------------------------------------------------------------
Dated: June 11, 2013.
Vivian Horovitch-Kelley,
NCI Project Clearance Liaison, National Institutes of Health.
[FR Doc. 2013-14643 Filed 6-18-13; 8:45 am]
BILLING CODE 4140-01-P
